-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Sempra, Lowers Price Target to $90

Benzinga·10/12/2026 19:50:45
Listen to the news
Barclays analyst Nicholas Campanella maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $103 to $90.